Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Bao

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Zhonghua Yi Xue Za Zhi|January 8, 2013
[Inhibitory effect of adenovirus-mediated D2S gene plus bromocriptine therapy on primary cultures of human non-functioning pituitary adenoma cells]Zhen-kun Xiong, Wei-qiang Li, Jie Liu, et al.
Endocrine|August 19, 2019
Multidisciplinary team efforts improve the surgical outcomes of sellar region lesions during pregnancyHui Ping Zhong, Hao Tang, Yong Zhang, et al.
Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi|January 19, 2007
Diagnostic value of CTA and MRA in intracranial traumatic aneurysmsYun-jun Yang, Wei-jian Chen, Yong Zhang, et al.
Molecular and Cellular Endocrinology|September 18, 2020
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonistsZerui Wu, Yongzhi Zheng, Wanqun Xie, et al.
Zhonghua Yi Xue Za Zhi|May 11, 2010
[Natural history study of postoperative residual non-functioning pituitary adenomas]Zhe-bao Wu, Yong Chen, Qing-ping Lü, et al.
Acta Pharmacologica Sinica|January 27, 2022
ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathwayLin Cai, Ze-Rui Wu, Lei Cao, et al.
Journal of Neuro-Oncology|January 12, 2010
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behaviorZhe Bao Wu, Wei Ming Zheng, Zhi Peng Su, et al.
Neuro-Oncology|November 13, 2024
TRIM21-mediated ubiquitination and phosphorylation of ERK1/2 promotes cell proliferation and drug resistance in pituitary adenomasYanting Liu, Fang Liu, Chuanbao Li, et al.
Cancers|February 24, 2024
Alternations of Blood Pressure Following Surgical or Drug Therapy for ProlactinomasYijun Cheng, Dapeng Wang, Hao Tang, et al.
Biochemical and Biophysical Research Communications|March 10, 2021
Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent mannerYu Cai, Wei Ting Gu, Kang Cheng, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Zhonghua Yi Xue Za Zhi|January 8, 2013
[Inhibitory effect of adenovirus-mediated D2S gene plus bromocriptine therapy on primary cultures of human non-functioning pituitary adenoma cells]Zhen-kun Xiong, Wei-qiang Li, Jie Liu, et al.
Endocrine|August 19, 2019
Multidisciplinary team efforts improve the surgical outcomes of sellar region lesions during pregnancyHui Ping Zhong, Hao Tang, Yong Zhang, et al.
Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi|January 19, 2007
Diagnostic value of CTA and MRA in intracranial traumatic aneurysmsYun-jun Yang, Wei-jian Chen, Yong Zhang, et al.
Molecular and Cellular Endocrinology|September 18, 2020
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonistsZerui Wu, Yongzhi Zheng, Wanqun Xie, et al.
Zhonghua Yi Xue Za Zhi|May 11, 2010
[Natural history study of postoperative residual non-functioning pituitary adenomas]Zhe-bao Wu, Yong Chen, Qing-ping Lü, et al.
Acta Pharmacologica Sinica|January 27, 2022
ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathwayLin Cai, Ze-Rui Wu, Lei Cao, et al.
Journal of Neuro-Oncology|January 12, 2010
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behaviorZhe Bao Wu, Wei Ming Zheng, Zhi Peng Su, et al.
Neuro-Oncology|November 13, 2024
TRIM21-mediated ubiquitination and phosphorylation of ERK1/2 promotes cell proliferation and drug resistance in pituitary adenomasYanting Liu, Fang Liu, Chuanbao Li, et al.
Cancers|February 24, 2024
Alternations of Blood Pressure Following Surgical or Drug Therapy for ProlactinomasYijun Cheng, Dapeng Wang, Hao Tang, et al.
Biochemical and Biophysical Research Communications|March 10, 2021
Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent mannerYu Cai, Wei Ting Gu, Kang Cheng, et al.
Pageof 10